Uganda is quietly building a strong case for self reliance and economic empowerment through deliberate industrial policy, with the pharmaceutical sector emerging as one of the most notable success stories. Strategic government directives have significantly increased the share of medicines sourced locally by the National Medical Stores, the agency responsible for procuring and distributing drugs to public health facilities across the country.
A decade ago, Uganda relied heavily on imported medicines. In 2015, the National Medical Stores sourced only 6 percent of its supplies from domestic pharmaceutical manufacturers. This heavy dependence on imports left the country vulnerable to foreign exchange pressures, supply chain disruptions, and missed opportunities for local industrial growth.
Recognizing these challenges, the government introduced a clear policy directive requiring public procurement agencies to prioritize Ugandan manufacturers whenever equivalent medicines are produced locally. Imports would only be considered for drugs that are not available within the country.
The policy has since delivered remarkable results. Today, about 64 percent of the medicines procured by the National Medical Stores come from local manufacturers. The dramatic increase reflects the impact of deliberate efforts to strengthen domestic production and promote Ugandan industry.
Several complementary initiatives have helped drive this transformation. Among them is the Buy Uganda Build Uganda program, commonly known as BUBU, which encourages government institutions to prioritize locally produced goods and services. Public procurement rules also provide a 15 percent price preference for local companies participating in government tenders, giving domestic firms a competitive advantage.
In addition, authorities introduced higher import verification fees on certain essential medicines, a move designed to discourage unnecessary imports while encouraging local pharmaceutical production.
These measures have created a strong incentive for investment in the local pharmaceutical industry. Manufacturers have expanded production lines, upgraded facilities, and increased output of generic drugs and other essential medicines.
The sector now includes dozens of licensed pharmaceutical firms, a significant increase compared to the mid 2010s. This growth has created skilled employment opportunities while helping build technical expertise within Uganda’s manufacturing ecosystem.
Beyond job creation, the shift toward local sourcing has broader economic benefits. By directing public procurement spending into domestic industry, the government is supporting value addition, strengthening small and medium enterprises, and promoting import substitution. This helps reduce pressure on foreign exchange reserves while keeping more economic activity within the national economy.
The policy shift is also improving the resilience of Uganda’s healthcare supply chain. Local production reduces dependence on international suppliers, which can be affected by global disruptions, shipping delays, or currency volatility.
For public health facilities across the country, especially in rural areas, this has helped stabilize the availability of essential medicines. A stronger domestic supply base can improve the reliability of drug distribution and support more consistent access to treatment.
Challenges still remain. Industry experts note that maintaining consistent quality standards, scaling production to meet full national demand, and addressing production costs are key areas that require continued attention.
However, the overall direction of Uganda’s pharmaceutical sector remains strongly positive. National development strategies now include ambitions to further expand local production of essential medicines, building on the progress already achieved.
Uganda’s experience offers an important lesson for developing economies seeking greater economic independence. By aligning public procurement policies with domestic industrial capacity, governments can stimulate local industries while strengthening strategic sectors such as healthcare.
The transformation from 6 percent to 64 percent local sourcing illustrates how effective policy can reshape an industry. In an era of global uncertainty and supply chain disruptions, Uganda’s approach demonstrates that thoughtful industrial policy can deliver both economic and social benefits.
